These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 20847582)

  • 1. Expression of IL-17 and its role in bone destruction in human middle ear cholesteatoma.
    Haruyama T; Furukawa M; Kusunoki T; Onoda J; Ikeda K
    ORL J Otorhinolaryngol Relat Spec; 2010; 72(6):325-31. PubMed ID: 20847582
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Expression and significance of nuclear factor-kappa B ligand and correlation factor in the tissue of otitis media with cholesteatoma].
    Xia M; Ding S; Zhang H; Liu F; Yin H; Xu A
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2007 Apr; 21(7):315-7. PubMed ID: 17580719
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aural cholesteatoma: role of tumor necrosis factor-alpha in bone destruction.
    Sastry KV; Sharma SC; Mann SB; Ganguly NK; Panda NK
    Am J Otol; 1999 Mar; 20(2):158-61. PubMed ID: 10100515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Is reuse of autologous ear ossicles in cholesteatoma or chronic suppurative otitis media justified?].
    Peng JC; Hoppe F
    Laryngorhinootologie; 1994 Jul; 73(7):375-80. PubMed ID: 7916783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aggressiveness and quantification of epithelial proliferation of middle ear cholesteatoma by MIB1.
    Mallet Y; Nouwen J; Lecomte-Houcke M; Desaulty A
    Laryngoscope; 2003 Feb; 113(2):328-31. PubMed ID: 12567091
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of ErbB-2 protein in human middle ear cholesteatomas.
    Sakamoto T; Kondo K; Yamasoba T; Suzuki M; Sugasawa M; Kaga K
    Laryngoscope; 2004 Nov; 114(11):1988-91. PubMed ID: 15510028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fascin expression in cholesteatoma: correlation with destruction of the ossicular chain and extent of disease.
    Binnetoglu A; Sari M; Baglam T; Erbarut Seven I; Yumusakhuylu AC; Topuz MF; Batman C
    Clin Otolaryngol; 2015 Aug; 40(4):335-40. PubMed ID: 25581788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of the IL-6/JAK/STAT3 signaling pathway in human middle ear cholesteatoma epithelium.
    Liu W; Xie S; Chen X; Rao X; Ren H; Hu B; Yin T; Xiang Y; Ren J
    Int J Clin Exp Pathol; 2014; 7(2):709-15. PubMed ID: 24551293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The morphological study of eroded auditory ossicles by cholesteatoma].
    Ma Y; Ye S
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2007 Jan; 21(1):10-2. PubMed ID: 17438855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acquired and congenital cholesteatoma: determination of tumor necrosis factor-alpha, intercellular adhesion molecule-1, interleukin-1-alpha and lymphocyte functional antigen-1 in the inflammatory process.
    Akimoto R; Pawankar R; Yagi T; Baba S
    ORL J Otorhinolaryngol Relat Spec; 2000; 62(5):257-65. PubMed ID: 10965261
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The imbalance of enzymatic antioxidants in cholesteatoma.
    Eskiizmir G; Yuceturk AV; Onur E; Var A; Temiz P
    Acta Otolaryngol; 2009 Nov; 129(11):1187-91. PubMed ID: 19863309
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Epithelium-stroma interaction in cholesteatoma of the middle ear].
    Jacob R; Welkoborsky HJ; Mann W
    Laryngorhinootologie; 2001 Jan; 80(1):11-7. PubMed ID: 11272241
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of BMP-2, BMP-4 and BMP-6 on bone destruction of cholesteatoma presence.
    Oger M; Alpay HC; Orhan I; Onalan EE; Yanilmaz M; Sapmaz E
    Am J Otolaryngol; 2013; 34(6):652-7. PubMed ID: 23927997
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of RANKL and proliferation abilities of cultured human middle ear cholesteatoma epithelial cells.
    Miyasato M; Takeno S; Hirakawa K
    Hiroshima J Med Sci; 2013 Mar; 62(1):1-6. PubMed ID: 23600327
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of RANKL and OPG in middle ear cholesteatoma tissue.
    Jeong JH; Park CW; Tae K; Lee SH; Shin DH; Kim KR; Park YW
    Laryngoscope; 2006 Jul; 116(7):1180-4. PubMed ID: 16826057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Attic cholesteatoma with extension into the tympanum.
    Pulec JL; Deguine C
    Ear Nose Throat J; 2000 May; 79(5):340. PubMed ID: 10832195
    [No Abstract]   [Full Text] [Related]  

  • 17. Analysis of histopathological aspects and bone destruction characteristics in acquired middle ear cholesteatoma of pediatric and adult patients.
    Aslıer M; Erdag TK; Sarioglu S; Güneri EA; Ikiz AO; Uzun E; Özer E
    Int J Pediatr Otorhinolaryngol; 2016 Mar; 82():73-7. PubMed ID: 26857319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Congenital cholesteatoma clinical features and surgical results.
    Kojima H; Tanaka Y; Shiwa M; Sakurai Y; Moriyama H
    Am J Otolaryngol; 2006; 27(5):299-305. PubMed ID: 16935171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comparative analysis of the proliferative capacity of cholesteatomas].
    Bernal Sprekelsen M; Ebmeyer J; Buchbinder A; Sudhoff H
    Acta Otorrinolaringol Esp; 2000 May; 51(4):299-307. PubMed ID: 10984952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The expression of Ras protein in human middle ear cholesteatoma].
    Xu Y; Jin K; Dong W
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 1999 Apr; 34(2):74-6. PubMed ID: 12764851
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.